Phase 2 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a head and neck cancer that has not spread to other parts of the body
- People aged between 18 and 65 years old (inclusive)
- People whose general health and ability to carry out daily activities meets a certain level, as measured by a standard medical scoring system known as the ECOG scale (score of 2 or lower — confirm with trial site)
- People whose treatment plan includes radiation therapy, either alone or combined with chemotherapy
- People whose major organs (such as heart, liver, and kidneys) are functioning well
- People who are willing and able to sign a consent form agreeing to take part in the trial
Who may not be able to join:
- People who are known to have allergies to two or more different medications
- People whose treatment plan includes certain types of medications — such as anti-EGFR drugs or immune checkpoint inhibitors — that can cause or worsen inflammation of the mouth lining, started after radiotherapy begins
- People who have used antibiotics, antifungal medications, or antibacterial mouthwash within one month before joining the study
- People with poor oral hygiene or severe gum disease
- People who have previously received radiation therapy to the head or neck area
- People who have another serious illness or condition that the trial doctors consider makes participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xingchen Peng, Professor, West China Hospital
Phone: +8618980606753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The duration of severe oral mucositis (RTOG grade≥3)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.